套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-009808 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-009807 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0000950170-24-002661 Act: 34 Size: 10 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0000950170-23-073432 Act: 34 Size: 159 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0000950170-23-071093 Act: 34 Size: 517 KB 网页链接
$Lyra Therapeutics(LYRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000902664-23-005625 Act: 34 Size: 70 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-23-063137 Size: 20 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-060243 Act: 34 Size: 458 KB 网页链接
$Lyra Therapeutics(LYRA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-060298 Act: 34 Size: 8 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-23-233432 Act: 34 Size: 1 MB 网页链接